Remove 2023 Remove Compounding Remove Dosage
article thumbnail

Technology advancement driving growth of rapid sterility testing market

European Pharmaceutical Review

billion in 2023 to $4.3 It is expected hold a compound annual growth rate (CAGR) of 8.20 percent between 2023 and 2032. Furthermore, an increasing demand for the previously mentioned dosage forms is a key factor contributing to the expansion of the market. billion by 2032.

Dosage 98
article thumbnail

Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023

Pharmaceutical Technology

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference

ISPE

Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference. Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference. I presented on planning and executing and designing fill lines, RABS, Isolators, and transfers – along with the differences between processing potent compounds versus non- potent compounds. Trudy Patterson.

article thumbnail

Buccal drug delivery market to reach $7.1b by 2030

European Pharmaceutical Review

billion in 2023 to $7.13 This represents a compound annual growth rate (CAGR) of close to 10 percent. According to the report buccal delivery is the “most feasible and preferred choice compared to oral dosage forms, particularly among elderly patients.” The global buccal drug delivery market is projected to grow from $3.38

Dosage 52
article thumbnail

3D printing and personalised medicines: embracing innovative technologies

Hospital Pharmacy Europe

Supporting the successful compounding of drugs with 3D printing processes has the potential to not only fulfil unmet patient needs but also drive efficiencies in hospital pharmacies. These products require a high degree of adaptability, particularly in terms of dosage, to meet patients’ needs.

Hospitals 111
article thumbnail

Automation to accelerate biopharma in next decade

European Pharmaceutical Review

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 percent during the forecast period 2023-2033. million in 2023, according to the data. The market’s overall world revenue value will exceed $1,855.0

article thumbnail

France gets new sterile liquid drug manufacturing facility

European Pharmaceutical Review

The facility forms two new fully-automated production lines for liquid and freeze-dried drugs, including highly potent compounds and advanced therapies such as antibody drug conjugates (ADCs). The site will have approximately 100 employees and create 50 new jobs throughout 2023.